InVera Medical Receives FDA Clearance for InVera Infusion Device - a Novel Non-Thermal Catheter for Enhanced Infusion of Sclerosant for Chronic Venous Disease

Encouraging 12-month pilot clinical study results will be presented by Key Opinion Leader Dr. Lowell Kabnick at the prestigious Charing Cross Vascular Symposium in London on Tuesday, April 21st, 2026. GALWAY, Ireland, April 7, 2026 /PRNewswire/ -- InVera Medical, a medical device company...